KLK3 and Familial prostate cancer: In addition, we were able to link the practice-based records through unique NHI numbers to laboratory data and prostate cancer registrations, meaning that we could cross-validate information from practices and acquire comprehensive history on PSA testing and follow-up care, including specialist referrals and biopsy results.